Manpower Software PLC
19 March 2002
MANPOWER SOFTWARE PLC ("the Company")
AWARD OF CONTRACT
Manpower Software plc announces the third sale of its CRESTA software for use
within a key regional unit of the Territorial Army. The software is being used
to improve the readiness for active service of Territorial Army personnel. The
sale has an initial value of £255,000. It follows previous sales made to HQ
Medical Group, enabling that organisation to populate and manage field hospitals
within the Army Medical Services Territorial Army, and the Royal Engineers TA.
The CRESTA application was favourably mentioned in a Report* by the House of
Commons Select Committee on Defence in response to questions concerning the
readiness of the Territorial Army to carry out its objectives.
This further sale underlines the value that military organisations around the
world place on the ability to plan and manage the rapid deployment of their
forces using the latest innovative software available in an increasingly complex
environment. The same software is also the market leader in the cruise shipping
industry and is now being marketed to a wide range of businesses that need to
ensure they have the right people in the right place at the right time.
The Company's software has a proven track record in facilitating increased
performance of a business or organisation, directly boosting profitability.
The range of software modules is ideally suited to any company undertaking
either project-based work or when using highly skilled people, enabling
deadlines to be met by allocating the right resources for the life of the
project and avoiding the high cost of outside consultants.
*'The Strategic Defence Review: the Reserve Forces. Government Observations on
the Sixth Report from the Defence Committee of Session 2000-01. First Special
Report Session 2001-02'
For further information please contact:
Manpower Software plc
Simon Thorne, Finance Director (020) 7389 9500
Strand Partners Limited
Simon Raggett, Director (020) 7409 3494
Dated 19 March 2002
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.